| HR | 95% CI | p | |
---|---|---|---|---|
Major non-fatal adverse events (112 patients), univariate analysis | Â | Â | Â | Â |
Age | 1.02 | 1.00 | 1.03 | 0.001 |
Hypertension | 1.46 | 1.06 | 2.03 | 0.02 |
History of cancer | 1.56 | 1.11 | 2.20 | 0.009 |
Major non-fatal adverse events (112 patients), multivariate analysis | ||||
Age | 1.49 | 1.06 | 2.118 | 0.022 |
Recurrent episodes of IE (19 patients), univariate analysis | ||||
Staphylococcus aureus infection | 4.8 | 1.9 | 11.9 | 0.001 |
Right-sided endocarditis | 7.4 | 2.9 | 18.9 | 0.001 |
Spondylodiscitis | 6.8 | 2.6 | 17.8 | 0.004 |
Drug abuse | 10.3 | 4.1 | 25.6 | 0.001 |
Recurrent episodes of IE (19 patients), multivariate analysis | ||||
Drug abuse | 8.5 | 2.3 | 31 | 0.001 |